Key terms

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest AZN news

Yesterday 2:49pm ET What Fusion Pharmaceuticals (NASDAQ:FUSN) Acquisition Means for Investors Mar 27 6:25am ET AstraZeneca, Sanofi announce Beyfortus approved in Japan Mar 27 6:24am ET AstraZeneca’s Truqap with Faslodex approved by Japanese MHLW Mar 26 5:07am ET QQQ ETF Update, 3/26/2024 Mar 25 7:57am ET AstraZeneca’s Ultomiris Revolutionizes NMOSD Treatment Mar 25 7:10am ET FDA approves AstraZeneca’s Ultomiris for rare nerve disease NMOSD Mar 25 6:17am ET AstraZeneca reports Ultomiris approved in U.S. for adults with NMOSD Mar 22 5:58am ET QQQ ETF Update, 3/22/2024 Mar 21 11:36am ET AstraZeneca put volume heavy and directionally bearish Mar 21 10:16am ET AstraZeneca reports follow up results from FLAURA2 Phase 3 trial Mar 21 2:51am ET Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), AstraZeneca (AZN) and Biohaven Ltd. (BHVN) Mar 20 9:57am ET Wells Fargo downgraded, Best Buy upgraded: Wall Street’s top analyst calls Mar 20 8:21am ET Fusion Pharmaceuticals downgraded to Neutral from Buy at B. Riley Mar 20 8:19am ET Fusion Pharmaceuticals downgraded to Market Perform from Strong Buy at Raymond James Mar 20 6:54am ET Fusion downgraded to Sector Perform from Outperform at RBC Capital Mar 20 6:49am ET QQQ ETF Update, 3/20/2024 Mar 20 6:30am ET Wall Street Analysts Are Bullish on Top Healthcare Picks Mar 19 10:17pm ET Puma Biotechnology says court denied AstraZeneca’s motion for invalidity Mar 19 1:32pm ET This radiopharma name seen as ‘poised for takeout’ following Fusion deal Mar 19 12:55pm ET Actinium Pharmaceuticals price target raised to $30 from $20 at Maxim Mar 19 11:23am ET Actinium positioned for takeout after Fusion deal, says H.C. Wainwright Mar 19 10:06am ET Fusion Pharmaceuticals downgraded to Hold from Buy at Jefferies Mar 19 9:53am ET Snowflake, MongoDB downgraded to Sell: Wall Street’s top analyst calls Mar 19 6:58am ET AstraZeneca Bolsters Cancer Care with Fusion Buyout Mar 19 6:08am ET Fusion Pharmaceuticals downgraded to Market Perform from Outperform at Leerink Mar 19 5:20am ET Fusion Pharmaceuticals to be acquired by AstraZeneca in $2.4B transaction Mar 19 2:21am ET Analysts Offer Insights on Healthcare Companies: AstraZeneca (AZN), Intuitive Surgical (ISRG) and IN8bio (INAB) Mar 18 8:17am ET Checkpoint Therapeutics appoints Sharma to board of directors Mar 18 8:14am ET AstraZeneca announces analysis from its DUO-E Phase III trial Mar 18 7:19am ET AstraZeneca to expand savings programs for inhaled U.S. respiratory portfolio Mar 18 2:01am ET QQQ ETF Update, 3/18/2024

No recent press releases are available for AZN

AZN Financials

1-year income & revenue

Key terms

AZN Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

AZN Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms